VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 335 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2017. The put-call ratio across all filers is 1.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $400,000 | -16.7% | 25,100 | +8.7% | 0.05% | -34.6% |
Q4 2017 | $480,000 | -16.5% | 23,100 | -42.4% | 0.08% | -13.3% |
Q3 2017 | $575,000 | -17.3% | 40,099 | -0.2% | 0.09% | -21.7% |
Q2 2017 | $695,000 | -60.7% | 40,199 | -74.9% | 0.12% | -71.8% |
Q1 2017 | $1,768,000 | -31.7% | 160,299 | -10.1% | 0.41% | -47.8% |
Q4 2016 | $2,589,000 | +0.0% | 178,299 | +81.2% | 0.78% | -21.2% |
Q1 2016 | $2,588,000 | – | 98,400 | – | 0.99% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |